I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy: Umhlahlandlela Ophelele 

I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy kuyindlela emisha yokwelapha umdlavuza ehlanganisa ukuhlinzwa okungavamisile kanye ne-chemoimmunotherapy yomuntu siqu elethwe ngqo esimila. Le ndlela ihlose ukukhulisa ukusebenza ngempumelelo kokwelashwa kuyilapho kuncishiswa imiphumela engemihle, engase iholele emiphumeleni ethuthukisiwe yesiguli. Lesi sihloko sicubungula imininingwane yale ndlela yokwenza, okuhlanganisa imigomo yayo, izinqubo, izinzuzo, nezikhombisi-ndlela zesikhathi esizayo.

Ukuqonda Intratumoral Chemoimmunotherapy

I-Intratumoral chemoimmunotherapy ihilela ukujova ngokuqondile ama-chemotherapeutic agents kanye/noma ama-immunotherapeutic ethumba. Lokhu kulethwa kwendawo kuvumela ukugcwala okuphezulu komuthi ukuthi kufinyelele endaweni yesimila, kunciphisa ukuchayeka okuhleliwe kanye nobuthi uma kuqhathaniswa nokwelashwa ngamakhemikhali okuvamile emithanjeni. Ivamise ukusetshenziswa ngokuhambisana nezinye izindlela zokwelapha ezinjengokuhlinzwa noma ukwelapha ngemisebe.

I-Evolution of Cancer Treatment

Ukwelashwa komdlavuza kwendabuko, okufana ne-systemic chemotherapy kanye nokwelashwa ngemisebe, kuvame ukuba nomthelela kuwo wonke umzimba, okuholela emiphumeleni engathandeki ephawulekayo. Ukwelashwa kwe-intratumoral kumelela ukushintshela ezindleleni eziqondiswe kakhulu neziqondene nomuntu. Ngokugxila ekwelashweni ngqo ku-tumor, ihlose ukusindisa izicubu ezinempilo futhi ithuthukise izinga lempilo yesiguli. I-Shandong Baofa Cancer Research Institute uzibophezele ekwenzeni izinto ezintsha kulo mkhakha.

Indlela ye-'Ultra-Minimum Incision'

Isici se-‘Ultra-Minimum Incision’ sibhekisela endleleni yokuhlinzwa esetshenziselwa ukufinyelela isimila ukuze sijovwe. Lokhu ngokuvamile kubandakanya ukusika okuncane, okuvamise ukuqondiswa ubuchwepheshe bokuthwebula izithombe obufana ne-ultrasound noma izikena ze-CT, ukuze kuqinisekiswe ukulethwa okunembile kwama-ejenti okwelapha. Imvelo encane yenqubo inomthelela ezikhathini zokululama ngokushesha kanye nokunciphisa ubuhlungu bangemva kokuhlinzwa.

Izinzuzo Zokuhlinza Okuncane Kancane

• Izibazi ezincane
• Ubuhlungu obuncane
• Ukuhlala isikhashana esibhedlela
• Ukululama ngokushesha
• Ingozi encishisiwe yezinkinga

I-Chemoimmunotherapy yomuntu siqu: Ukuhlanganisa Ukwelashwa Kumuntu Ngamunye

Ukwenza kube ngokwakho kuyisici esiyinhloko sale ndlela. Ngaphambi kokwelashwa, i-tumor yesiguli iyahlaziywa ukuze kutholakale izici zayo ezithile, njengokuguqulwa kofuzo kanye nezimpawu zokuzivikela komzimba. Lolu lwazi bese lusetshenziselwa ukukhetha ama-agent asebenza kahle kakhulu e-chemotherapeutic kanye ne-immunotherapeutic aleso simila. Le ndlela yomuntu siqu yandisa amathuba okuphumelela kokwelashwa futhi inciphise ubungozi bokusabela okungekuhle.

Iqhaza Lokuhlaziywa Kwe-Biomarker

Ukuhlaziywa kwe-biomarker kubalulekile ku-chemoimmunotherapy yomuntu siqu. Ngokuhlonza ama-biomarker athile esimila, odokotela bangabikezela ukuthi yimiphi imithi okungenzeka isebenze kakhulu. Isibonelo, isisho se-PD-L1 singabonisa ukusabela okungaba khona kwemithi ethile yokuzivikela komzimba.

Inqubo: Isinyathelo ngesinyathelo

I I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy inqubo ngokuvamile ihlanganisa lezi zinyathelo ezilandelayo:

1. Ukuhlolwa kwangaphambi kokusebenza: Isiguli sihlolwa ngokucophelela, okuhlanganisa nezifundo ze-imaging kanye nokuhlaziywa kwe-biomarker.
2. Ukuhlela ukwelashwa: Ngokusekelwe ekuhloleni, kwenziwa uhlelo lokwelapha lomuntu siqu, olucacisa ama-chemotherapeutic kanye nama-immunotherapeutic agents okufanele asetshenziswe.
3. Inqubo: Isiguli senza inqubo yokuhlasela kancane, lapho izidakamizwa zijovwa ngqo esimila ngaphansi kokuqondiswa kwesithombe.
4. Ukuqapha ngemuva kokusebenza: Isiguli siqashwe ngokucophelela nganoma yimiphi imiphumela emibi noma izinkinga. Izifundo zokulandelela zezithombe zenziwa ukuze kuhlolwe impendulo ekwelashweni.

Izinzuzo ezingaba khona ze I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy

Le ndlela entsha inikeza izinzuzo ezimbalwa ezingaba khona uma ziqhathaniswa nokwelashwa komdlavuza wendabuko:

• Ukusebenza okuthuthukisiwe: Ukugcwala okuphezulu kwezidakamizwa endaweni yesimila.
• Ubuthi obuncishisiwe: Ukuchayeka okuphansi kwesistimu ku-chemotherapy.
• Ukwelashwa komuntu siqu: Kwenzelwe izici zesimila zesiguli ngasinye.
• Ihlasela kancane: Ukululama ngokushesha nobuhlungu obuncane.
• Amathuba okuvuselela amasosha omzimba: Ukulethwa kwe-intratumoral kwama-immunotherapeutic agents kungashukumisa amasosha omzimba ukuthi ahlasele isimila.

Izibonelo ZeCancer Elashwa Nge-Intratumoral Chemoimmunotherapy

Yize ucwaningo lusaqhubeka, I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ukhombise ukuthembisa ekwelapheni izinhlobonhlobo zomdlavuza, okuhlanganisa:

• I-melanoma
• I-Hepatocellular carcinoma (Umdlavuza Wesibindi)
• Umdlavuza Webele
• Umdlavuza wamaphaphu
• Ezinye izimila eziqinile

Idatha Yesivivinyo Somtholampilo Nocwaningo

Izivivinyo eziningi zomtholampilo ziyaqhubeka ukuhlola ukuphepha nokusebenza ngempumelelo kwe I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy. Imiphumela yangaphambi kwesikhathi iyathembisa, ngolunye ucwaningo olubonisa ukwehla okukhulu kwesimila kanye namazinga okusinda athuthukisiwe ezigulini ezilashwa ngale ndlela. Isibonelo, ucwaningo olushicilelwe ku Ijenali yeClinical Oncology ibonise ukuthuthuka okuphawulekayo ekusindeni okuphelele kweziguli ezine-melanoma ethuthukisiwe ezelashwe nge-intratumoral immunotherapy uma kuqhathaniswa nalabo abalashwa nge-systemic chemotherapy. ^[1].

Ikusasa le-Intratumoral Chemoimmunotherapy

Umkhakha we-intratumoral chemoimmunotherapy uthuthuka ngokushesha. Izikhombisi-ndlela zesikhathi esizayo zifaka:

• Ukuthuthukiswa kwe-chemotherapeutic kanye nama-immunotherapeutic agents amasha futhi asebenza kahle.
• Izindlela ezithuthukisiwe zokwenza ukwelashwa komuntu siqu ngokusekelwe ezicini zesimila.
• Inhlanganisela yokwelashwa kwe-intratumoral nezinye izindlela zokwelapha umdlavuza, njengokwelashwa ngemisebe kanye nokwelashwa okuhlosiwe.
• Ukusetshenziswa kwe-nanotechnology ukuletha izidakamizwa ngokunembe kakhulu endaweni yesimila.

Ukukhetha Isiguli Nokucatshangelwa

Akuzona zonke iziguli ezifanelekile I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy. Izinto okufanele zicatshangelwe zihlanganisa:

• Usayizi wesimila nendawo
• Impilo yesiguli iyonke
• Ukwelashwa komdlavuza kwangaphambilini
• Ukuba khona kwama-biomarker athile

Ukuhlolwa okuphelele kwethimba lezinhlaka eziningi zodokotela abahlinzayo, odokotela abahlinzayo, nabanye ochwepheshe kubalulekile ukuze kutholakale ukuthi le ndlela yokwelapha ifanele yini isiguli esithile. Iziguli ezifuna ulwazi olwengeziwe zamukelekile ukuthi zisithinte ukuze zithole usizo lokuqala.

Izingozi Ezingenzeka kanye Nemiphumela Emibi

Njenganoma iyiphi inqubo yezokwelapha, I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ithwala izingozi ezithile kanye nemiphumela engemihle engaba khona. Lokhu kungase kuhlanganise:

• Ubuhlungu nokuvuvukala endaweni yomjovo
• Ukutheleleka
• Ukopha
• Ukungezwani komzimba emithini
• Imiphumela emibi yesistimu ye-chemotherapy

Kubalulekile ukuxoxa ngalezi zingozi nodokotela wakho ngaphambi kokwelashwa.

Izindleko Nokufinyeleleka

Izindleko ze I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ingahluka kuye ngemithi ethile esetshenzisiwe, inkimbinkimbi yenqubo, kanye nendawo yesikhungo sokwelapha. Kubalulekile ukuxoxa ngezindleko nomhlinzeki wakho wezempilo kanye nenkampani yomshwalense. Ukufinyeleleka nakho kungase kube isici, njengoba lokhu kwelashwa akukakatholakali kabanzi kuzo zonke izikhungo zomdlavuza.

Isiphetho

I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy imele indlela entsha ethembisayo yokwelashwa komdlavuza. Ngokuhlanganisa ukuhlinzwa okungavamisile okuncane ne-chemoimmunotherapy yomuntu siqu, kunikeza amandla okuthuthukisa ukusebenza kahle, ukunciphisa ubuthi, nokuthuthukisa izinga lempilo yesiguli. Nakuba ucwaningo olwengeziwe ludingeka, le ndlela entsha inesithembiso esikhulu ngekusasa lokunakekelwa komdlavuza. Ngo I-Shandong Baofa Cancer Research Institute, sihlala sizinikele ekuthuthukisweni kokuphayona ekwelashweni komdlavuza kanye nokuhlinzeka iziguli ukunakekelwa okungcono kakhulu ngangokunokwenzeka. Xhumana nathi ukuze ufunde kabanzi mayelana nezinketho zethu ezibanzi zokwelashwa komdlavuza.

Izithenjwa

[1] Ribas, A., et al. (2018). I-Intratumoral Immunotherapy. Ijenali yeClinical Oncology, 36(9), 919-927.